Korean cosmetic manufacturing is a deep, competent industry with a long tail of intermediaries attached to it. Most of those intermediaries are legitimate. Some add genuine value. A few are a website and an email address between you and a factory you will never be told the name of.
Sorting them out is not about detecting fraud — outright fraud is rare. It is about knowing what each party actually controls, so you can tell whether the person quoting you can deliver what they are quoting.
First, Know What You Are Talking To
Four kinds of company answer the same enquiry, and they will all describe themselves as a manufacturing partner.
A factory owns production lines. It makes things. It may have limited formulation capability, may not speak your language commercially, and usually wants larger volumes than a first-time brand can commit to.
A formulation house or lab develops formulas. Some own production; many do not and place work with factories they know.
A development partner or trading company coordinates: brief, formulation, packaging sourcing, testing, export documentation. It does not own the lines, and being honest about that is the mark of a good one.
A broker forwards your enquiry and marks up the reply.
None of these is inherently better. The fourth is worse than the others mainly because it is usually presented as one of the first three. What you want is a clear answer to what do you actually control, and a party that answers it plainly is telling you something useful regardless of which category it falls into.
Seoul Coslab is the third kind. We coordinate development and manufacture through Korean partners. That is stated on what we do rather than implied, because the alternative is a conversation where you assume we own lines and we let you.
The Questions That Matter
"Do you own the production line, or do you place the work?"
Both answers are fine. An evasive answer is not.
If the reply describes an in-house facility, ask which products are made there. Many companies own a line for one format and place everything else. If the reply is that work is placed with partners, ask how partners are selected and who is accountable when a batch fails specification.
The follow-up that reveals the most: who signs the specification? Whoever does is the party you can hold to it.
"Who owns the formula, and is it exclusive to us?"
Formula ownership, exclusivity scope and exclusivity duration are three separate terms. None is implied by the word ODM. A brand that assumes exclusivity it never negotiated has bought a private label product at ODM prices — the distinction is set out in OEM, ODM and private label compared.
Ask for the answer in writing, before development starts. Renegotiating after a formula exists is much harder, because by then you have already paid for it.
"Which certifications apply to the facility making our product?"
Certifications belong to facilities, not to companies. A partner that lists certifications on its website without saying which facility holds them is describing its network, not your product.
The right question is narrower: for the facility that will make our specific product, what certifications are current, and can we see them? Then ask what your destination market actually requires, because the answer is often less than the list you were shown and occasionally something that was not on it. See what each market requires.
"What does the quote include, and what is it excluding?"
A per-unit price with nothing around it is not comparable to anything. Ask which of these are in the number and which arrive later:
- Formulation development
- Sampling rounds — and how many before charges begin
- Stability and challenge testing
- Compatibility testing with the pack
- Packaging components, tooling, decoration
- Artwork adaptation and printing plates
- Export documentation and certificates
- Shipping terms
Two quotes are only comparable once both are expanded this way, and expanding them frequently reverses which one is cheaper.
"What happens if a batch fails specification?"
Ask before you need to know. Who inspects, against what specification, at what point, and what happens to a batch that fails — rework, replacement, credit, or a conversation.
A partner with a real answer has been through it. A partner without one has either been lucky or is not the party that would handle it. Our quality control and testing process exists because this question deserves a concrete answer rather than reassurance.
"What documentation do we get, and when?"
You will need specifications, certificates of analysis by batch, stability and challenge reports, compatibility data, allergen and composition statements, and free sale documentation. Different markets want different subsets, and some retailers want more than the regulator does.
Ask for the list up front. A partner that produces this as a matter of course is running a system; one that assembles it on request each time will be slow every time you add a market. See export and regulatory support for where the handover sits.
Signals Worth Reading
Good signs
- Says no to something. A partner who tells you your timeline is unrealistic, or that a claim will not survive your destination market, is more valuable than one who agrees with everything
- Asks about your markets before quoting. It changes the formula, not just the label
- Gives ranges with the variables attached rather than a single confident number
- Is specific about what it does not control
Warning signs
- A firm price before the brief exists. Cosmetic pricing depends on formula, pack, volume and market; a number that arrives before those are known is either padded or will move
- Certifications listed without a facility attached
- Reluctance to name what is placed with partners versus made in-house
- MOQ quoted as a single number with no reference to format, packaging or route — see what actually determines cosmetic MOQ
- Claims about client brands under NDA. Either it is confidential and cannot be discussed, or it can. The middle position is a sales technique
- Agreement to a claim you suspect is not permitted in your market. This one is not a red flag about competence, it is a red flag about what will happen at customs
A Practical Sequence
You do not need a formal audit to make a good decision. You need to escalate commitment in steps.
- Send the same brief to three or four candidates. Same document, same questions. Differences in the replies are informative in a way that differences in the enquiries are not.
- Compare how they answer, not just what they quote. Who asked about your markets? Who told you something you did not want to hear?
- Ask the ownership and documentation questions in writing. Written answers are a different commitment from a call.
- Buy a sample round before you commit to a project. It is the cheapest information available: you learn the sample quality, the turnaround, and how they respond to feedback.
- Expand the quote before comparing. Line by line, using the list above.
- Get formula ownership and exclusivity in the agreement. Before development starts, not after.
Steps four and five are where most of the signal is, and both are cheap.
What You Cannot Learn From a Website
Two things, and they are the two that matter most.
How they behave when something goes wrong. Every project has a moment — a failed stability result, a component delayed, a market rejecting a claim. What you want to know is whether the problem reaches you early with options attached, or late with an explanation attached. You cannot learn this before it happens. You can only reduce the cost of finding out, by starting with a smaller commitment than your ambition.
Whether they will tell you your idea is wrong. The most valuable thing a manufacturing partner does is prevent you from spending a season and a budget on a product that could not have worked — the claim that will not clear, the format that cannot carry the active, the launch date that was never achievable. That requires being willing to lose the sale. You get a preview of it in the first conversation: ask something slightly unreasonable and see whether the answer is yes.
Frequently Asked Questions
Should we work directly with a factory instead of a partner?
If you have formulation capability, regulatory capability and volumes a factory wants, direct is cheaper and there is no reason not to. Most first-time brands have none of those three, and the coordination work still has to happen — done in-house, by a consultant, or by a development partner. The question is not direct versus indirect, it is who is doing the coordination and whether you are paying for it visibly or invisibly.
How do we know a supplier is not just a broker?
Ask what they control and who signs the specification. A development partner that places production with factories is not a broker — the difference is that a partner takes responsibility for the specification and the outcome, while a broker forwards messages. Evasiveness about which factory makes your product is the signal, not the fact of placing work externally.
Is a low quote a warning sign?
Not on its own, but an unexpanded quote is. Ask which of development, sampling, testing, components, tooling, artwork, documentation and shipping are inside the number. Low quotes are frequently low because several of those sit outside it. Once both quotes are expanded, compare again.
How many suppliers should we approach?
Three or four, with the same brief. Fewer gives you no basis for comparison; more turns into administration and dilutes the quality of each conversation. Send the identical document to each — differences in the replies mean something only if the inputs were the same.
What should we ask about certifications?
Ask which certifications are current for the specific facility that will make your product, and ask to see them. Certifications belong to facilities rather than companies, so a list on a website describes a network. Then check what your destination market actually requires — sometimes less than the list, occasionally something not on it.